1. Academic Validation
  2. Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation

Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation

  • Cell. 2016 Sep 22;167(1):187-202.e17. doi: 10.1016/j.cell.2016.09.001.
Franklin L Zhong 1 Ons Mamaï 2 Lorenzo Sborgi 3 Lobna Boussofara 4 Richard Hopkins 5 Kim Robinson 6 Ildikó Szeverényi 6 Takuya Takeichi 7 Reshmaa Balaji 6 Aristotle Lau 6 Hazel Tye 8 Keya Roy 6 Carine Bonnard 6 Patricia J Ahl 5 Leigh Ann Jones 5 Paul J Baker 8 Lukas Lacina 6 Atsushi Otsuka 9 Pierre R Fournie 10 François Malecaze 10 E Birgitte Lane 6 Masashi Akiyama 11 Kenji Kabashima 12 John E Connolly 5 Seth L Masters 8 Vincent J Soler 10 Salma Samir Omar 13 John A McGrath 14 Roxana Nedelcu 15 Moez Gribaa 16 Mohamed Denguezli 4 Ali Saad 16 Sebastian Hiller 3 Bruno Reversade 17
Affiliations

Affiliations

  • 1 Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Institute of Molecular and Cellular Biology, A(∗)STAR, Singapore 138632, Singapore. Electronic address: [email protected].
  • 2 Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Laboratory of Human Cytogenetic, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Rue Ibn El Jazzar, 4000 Sousse, Tunisia.
  • 3 Biozentrum, University of Basel, 4056 Basel, Switzerland.
  • 4 Department of Dermatology and Venerology, Farhat Hached University Hospital, Rue Ibn El Jazzar, 4000 Sousse, Tunisia.
  • 5 Institute of Molecular and Cellular Biology, A(∗)STAR, Singapore 138632, Singapore.
  • 6 Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore.
  • 7 Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; St John's Institute of Dermatology, King's College London, Guy's Hospital, London SE1 4XA, United Kingdom.
  • 8 Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3010, Australia.
  • 9 Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
  • 10 Ophthalmology Department, Hôpital Pierre-Paul Riquet, University Toulouse Hospital, TSA 40031, Place Baylac, 31059 Toulouse Cedex 9, France; Team Epithéliums, physiopathologie et génétique oculaires, Unité "Différenciation Epithéliale et Autoimmunité Rhumatoïde, UMR 1056 Inserm, Université Paul Sabatier Toulouse III, FRE 3742 CNRS, Hôpital Purpan, 31059 Toulouse Cedex 9, France.
  • 11 Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • 12 Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
  • 13 Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Alexandria University, Alexandria 21411, Egypt.
  • 14 St John's Institute of Dermatology, King's College London, Guy's Hospital, London SE1 4XA, United Kingdom.
  • 15 Department of Pathophysiology II, National Institute for Infectious Diseases "Matei Bals," "Carol Davila" University of Medicine and Pharmacy, Bucharest 050474, Romania.
  • 16 Laboratory of Human Cytogenetic, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Rue Ibn El Jazzar, 4000 Sousse, Tunisia.
  • 17 Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Institute of Molecular and Cellular Biology, A(∗)STAR, Singapore 138632, Singapore; Medical Genetics Department, Koç University School of Medicine, 34010 Istanbul, Turkey; Department of Paediatrics, National University of Singapore, Singapore 119228, Singapore. Electronic address: [email protected].
Abstract

Inflammasome complexes function as key innate immune effectors that trigger inflammation in response to pathogen- and danger-associated signals. Here, we report that germline mutations in the inflammasome sensor NLRP1 cause two overlapping skin disorders: multiple self-healing palmoplantar carcinoma (MSPC) and familial keratosis lichenoides chronica (FKLC). We find that NLRP1 is the most prominent inflammasome sensor in human skin, and all pathogenic NLRP1 mutations are gain-of-function alleles that predispose to inflammasome activation. Mechanistically, NLRP1 mutations lead to increased self-oligomerization by disrupting the PYD and LRR domains, which are essential in maintaining NLRP1 as an inactive monomer. Primary keratinocytes from patients experience spontaneous inflammasome activation and paracrine IL-1 signaling, which is sufficient to cause skin inflammation and epidermal hyperplasia. Our findings establish a group of non-fever inflammasome disorders, uncover an unexpected auto-inhibitory function for the pyrin domain, and provide the first genetic evidence linking NLRP1 to skin inflammatory syndromes and skin Cancer predisposition.

Keywords

ASC; IL-1; MSPC; MSSE; NLRP1; cancer; gain-of-function; genodermatosis; germline; inflammasome; keratinocytes; keratosis lichenoides chronica; multiple self-healing squamous cell carcinoma; skin inflammation.

Figures